| |
 |
|
Class Information
Number: 514/18
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Peptide containing (e.g., protein, peptones, fibrinogen, etc.) doai > 3 or 4 peptide repeating units in known peptide chain
Description: Subject matter which contains an uninterrupted peptide chain of 3 or 4 peptide units.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7618945 |
Heteroaryl peptidomimetics as thrombin receptor antagonists |
Nov. 17, 2009 |
| 7615535 |
Inhibiting GS-FDH to modulate no bioactivity |
Nov. 10, 2009 |
| 7608592 |
HCV inhibitors |
Oct. 27, 2009 |
| 7608591 |
Targeted delivery to legumain-expressing cells |
Oct. 27, 2009 |
| 7608590 |
HCV NS-3 serine protease inhibitors |
Oct. 27, 2009 |
| 7605126 |
Acylaminoheteroaryl hepatitis C virus protease inhibitors |
Oct. 20, 2009 |
| 7598224 |
Dual chain synthetic heparin-binding growth factor analogs |
Oct. 6, 2009 |
| 7595299 |
Peptides as NS3-serine protease inhibitors of hepatitis C virus |
Sep. 29, 2009 |
| 7592316 |
Peptides as NS3-serine protease inhibitors of hepatitis C virus |
Sep. 22, 2009 |
| 7585845 |
Hepatitis C inhibitor compounds |
Sep. 8, 2009 |
| 7582605 |
Phosphorus-containing hepatitis C serine protease inhibitors |
Sep. 1, 2009 |
| 7582312 |
Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof |
Sep. 1, 2009 |
| 7579319 |
Methods for improving the structure and function of arterioles |
Aug. 25, 2009 |
| 7576062 |
Compounds with growth hormone releasing properties |
Aug. 18, 2009 |
| 7576061 |
Methods for preventing mitochondrial permeability transition |
Aug. 18, 2009 |
| 7575856 |
Compositions and methods for the evaluation and resuscitation of cadaveric hearts for transplant |
Aug. 18, 2009 |
| 7569548 |
Method of preparing peptide |
Aug. 4, 2009 |
| 7569547 |
Inhibiting furin with polybasic peptides |
Aug. 4, 2009 |
| 7560433 |
Treatment of multiple sclerosis (MS) |
Jul. 14, 2009 |
| 7557088 |
Methods and compositions for treating conditions |
Jul. 7, 2009 |
| 7550439 |
Methods for reducing oxidative damage |
Jun. 23, 2009 |
| 7547676 |
Antagonist peptides to the C5A chemotactic function of vitamin D binding protein |
Jun. 16, 2009 |
| 7544662 |
Polypeptides useful for appetite suppression |
Jun. 9, 2009 |
| 7541340 |
Methods for reducing CD36 expression |
Jun. 2, 2009 |
| 7541157 |
Method of screening groups of radioactive molecules and applications thereof |
Jun. 2, 2009 |
| 7538091 |
Intracellular delivery of biological effectors |
May. 26, 2009 |
| 7534438 |
Product and process for liquefaction of mucus or sputum |
May. 19, 2009 |
| 7534431 |
Methods and compositions for administering therapeutic and diagnostic agents |
May. 19, 2009 |
| 7528174 |
Selective targeting agents for mitochondria |
May. 5, 2009 |
| 7524820 |
Compounds of therapeutic value in the treatment of multiple sclerosis and other diseases wherein foamy cells are involved in the disease etiology |
Apr. 28, 2009 |
| 7521427 |
Peptidyl allyl sulfones |
Apr. 21, 2009 |
| 7517857 |
Immune-modulating peptide |
Apr. 14, 2009 |
| 7517855 |
Peptides which inhibit angiogenesis, cell migration, cell invasion and cell proliferation, compositions and uses thereof |
Apr. 14, 2009 |
| 7507719 |
Use of peptidic conjugates for preparing compositions for alopecia preventive and curative treatment |
Mar. 24, 2009 |
| 7504092 |
Cosmetic or pharmaceutical composition comprising peptides, uses and treatment processes |
Mar. 17, 2009 |
| 7498310 |
Cosmetic or dermatological preparations comprising oligopeptides for lightening the skin of age marks and/or for preventing tanning of the skin, in particular tanning of the skin caused by UV |
Mar. 3, 2009 |
| 7491704 |
Compounds for enzyme inhibition |
Feb. 17, 2009 |
| 7491703 |
Tetrapeptide regulating blood glucose level in diabetes mellitus |
Feb. 17, 2009 |
| 7491699 |
Peptide nanostructures and methods of generating and using the same |
Feb. 17, 2009 |
| 7485625 |
Inhibitors of hepatitis C virus NS3/NS4a serine protease |
Feb. 3, 2009 |
| 7482024 |
Compositions comprising an active agent |
Jan. 27, 2009 |
| 7476650 |
Enzyme inhibition |
Jan. 13, 2009 |
| 7470664 |
HCV NS3 protease inhibitors |
Dec. 30, 2008 |
| 7468354 |
Tissue specific prodrugs |
Dec. 23, 2008 |
| 7465710 |
Compounds for control of appetite, blood pressure, cardiovascular response, libido, and circadian rhythm |
Dec. 16, 2008 |
| 7459442 |
Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
Dec. 2, 2008 |
| 7459428 |
Method of regulating glucose metabolism, and reagents related thereto |
Dec. 2, 2008 |
| 7455840 |
Compositions and methods to reduce mutagenesis |
Nov. 25, 2008 |
| 7449447 |
Peptidomimetic NS3-serine protease inhibitors of hepatitis C virus |
Nov. 11, 2008 |
| 7449446 |
Combination product comprising melagatran and dexamethasone |
Nov. 11, 2008 |
|
|
|
